数字聚合酶链反应
结核分枝杆菌
肺结核
痰
聚合酶链反应
医学
肺结核
分子生物学
病毒学
生物
病理
基因
遗传学
作者
Ryota Ushio,Masaki Yamamoto,Kentaro Nakashima,Hiroki Watanabe,Kenjiro Nagai,Yuji Shibata,Ken Tashiro,Toshinori Tsukahara,Hideyuki Nagakura,Nobuyuki Horita,Takashi Sato,Masaharu Shinkai,Makoto Kudo,Atsuhisa Ueda,Takeshi Kaneko
出处
期刊:Tuberculosis
[Elsevier BV]
日期:2016-04-15
卷期号:99: 47-53
被引量:79
标识
DOI:10.1016/j.tube.2016.04.004
摘要
Summary Nucleic acid amplification tests are a major diagnostic tool for pulmonary tuberculosis (PTB). Recently, digital PCR (dPCR) assay has improved sensitivity for the detection of small copy numbers of target molecules. The aim of this study is to explore the utility of dPCR for detecting Mycobacterium tuberculosis (MTB) DNA in PTB patient plasma. Total DNA was purified from plasma samples of newly diagnosed sputum smear-positive PTB patients. Copy numbers of MTB-specific genes in the samples were quantified with dPCR assays targeted for IS6110 or gyrB . A total of 33 PTB patients were enrolled. Significant differences between PTB patients and controls were observed in copy numbers of both targets: IS6110 mean ± SD, 144.8 ± 538.3 vs 0.44 ± 0.49 (copies/20 μL, p = 0.004; Mann–Whitney U test) and gyrB mean ± SD, 359.0 ± 2116 vs 0.07 ± 0.28 (copies/20 μL, p = 0.011; Mann–Whitney U test), respectively. This test had sensitivities of 65% or 29% and a specificity of 93% or 100% with the IS6110 -targeted or gyrB -targeted assays, respectively. A dPCR assay successfully detected MTB DNA in PTB patient plasma. This minimally invasive and accurate method has potential to become an alternative diagnostic option.
科研通智能强力驱动
Strongly Powered by AbleSci AI